Business Combination - Pro Forma Information (Details) - Pharmagesic $ in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2024
USD ($)
| |
| Business Combination | |
| Net loss before taxes | $ (19,649) |
| Nonrecurring pro forma transaction costs | 4,900 |
| Success fees | $ 3,600 |
| X | ||||||||||
- Definition Amount of non-recurring adjustment made for the success fees paid to financial advisors which is directly attributable to business combinations during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Amount of non-recurring adjustment made for the pro-forma transaction costs incurred which is directly attributable to business combinations during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|